PARA-NITROBENZYL GLUTARYL GLYCINIC ACID
Star0
Identification
- Generic Name
- PARA-NITROBENZYL GLUTARYL GLYCINIC ACID
- DrugBank Accession Number
- DB08410
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 323.3013
Monoisotopic: 323.111735291 - Chemical Formula
- C14H17N3O6
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UIg gamma-1 chain C region Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- N-acyl-alpha amino acids
- Alternative Parents
- Nitrobenzenes / Nitroaromatic compounds / N-acyl amines / Secondary carboxylic acid amides / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organonitrogen compounds show 4 more
- Substituents
- Allyl-type 1,3-dipolar organic compound / Aromatic homomonocyclic compound / Benzenoid / C-nitro compound / Carbonyl group / Carboxamide group / Carboxylic acid / Fatty acyl / Fatty amide / Hydrocarbon derivative show 18 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- C-nitro compound, glycine derivative (CHEBI:44939)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- UCFVFUIGNWHAJJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C14H17N3O6/c18-12(2-1-3-13(19)16-9-14(20)21)15-8-10-4-6-11(7-5-10)17(22)23/h4-7H,1-3,8-9H2,(H,15,18)(H,16,19)(H,20,21)
- IUPAC Name
- 2-(4-{[(4-nitrophenyl)methyl]carbamoyl}butanamido)acetic acid
- SMILES
- OC(=O)CNC(=O)CCCC(=O)NCC1=CC=C(C=C1)[N+]([O-])=O
References
- General References
- Not Available
- External Links
- PDB Entries
- 1yef
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0818 mg/mL ALOGPS logP 1.09 ALOGPS logP 0.022 Chemaxon logS -3.6 ALOGPS pKa (Strongest Acidic) 3.65 Chemaxon pKa (Strongest Basic) -1.4 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 138.64 Å2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 78.59 m3·mol-1 Chemaxon Polarizability 31.53 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.681 Blood Brain Barrier + 0.7068 Caco-2 permeable - 0.6409 P-glycoprotein substrate Non-substrate 0.5218 P-glycoprotein inhibitor I Non-inhibitor 0.9167 P-glycoprotein inhibitor II Non-inhibitor 0.951 Renal organic cation transporter Non-inhibitor 0.9261 CYP450 2C9 substrate Non-substrate 0.8033 CYP450 2D6 substrate Non-substrate 0.8393 CYP450 3A4 substrate Non-substrate 0.631 CYP450 1A2 substrate Non-inhibitor 0.9088 CYP450 2C9 inhibitor Non-inhibitor 0.7518 CYP450 2D6 inhibitor Non-inhibitor 0.8969 CYP450 2C19 inhibitor Non-inhibitor 0.6862 CYP450 3A4 inhibitor Non-inhibitor 0.9469 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9326 Ames test AMES toxic 0.649 Carcinogenicity Non-carcinogens 0.8284 Biodegradation Ready biodegradable 0.6636 Rat acute toxicity 2.4922 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.816 hERG inhibition (predictor II) Non-inhibitor 0.7395
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0udi-7792000000-894478e7a8c7205db732 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 163.05016 predictedDeepCCS 1.0 (2019) [M+H]+ 165.6032 predictedDeepCCS 1.0 (2019) [M+Na]+ 173.40016 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsIg gamma-1 chain C region
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Immunoglobulin receptor binding
- Specific Function
- Not Available
- Gene Name
- IGHG1
- Uniprot ID
- P01857
- Uniprot Name
- Ig gamma-1 chain C region
- Molecular Weight
- 36105.695 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:31 / Updated at June 12, 2020 16:52